Attention:
Card image cap

Countering Fraud Risks in the Insurance Industry: A Blueprint for Your Business


Level: Intermediate
Runtime: 88 minutes
Recorded Date: June 01, 2023
Click here to share this program
Printer-Friendly Version

Agenda

Key issues that will be covered include:
  • Defending fraud on a broader scope including real-life case examples
  • The impact of fraud on carriers
  • Strategy for litigating fraud cases including ways experts commit fraud and how judges handle fraud cases

For NY - Difficulty Level: Both newly admitted and experienced attorneys

Description

The risk of fraud is ever-present; be it intentional or unintentional. Does defining fraud limit its actual scope? Have laws evolved to the extent that they incorporate every possible tactic being utilized by key players including insureds, experts, professionals, service providers, etc.? Fraud has many colors, and this underscores the need for insurers to recognize different fraud schemes and adopt a fraud risk strategy to help address susceptibility.

Join attorneys Kenneth P. Williams and A. Solomon Luwoye as they provide a comprehensive discussion of fraud risks in the current insurance ecosystem. Ken and Solomon, among other things, will also offer practical tips and strategies to mitigate pitfalls.

Provided By

Card image cap The Knowledge Group
Card image cap

Panelists

Card image cap

A. Solomon Luwoye

Associate
Segal McCambridge Singer & Mahoney

Solomon Luwoye concentrates his practice in civil litigation including areas of first-party and third-party no-fault insurance defense, insurance coverage disputes, and general negligence litigation. He has previously also spent a number of years as an insurance advisor for one of the largest brokerages in North America, which has provided him with a unique, behind-the-scenes, knowledge and set of skills when handling insurance-related matters.

Solomon earned his J.D. from the University of Detroit Mercy School of Law, cum laude.

Card image cap

Kenneth Williams

Shareholder
Segal McCambridge Singer & Mahoney, Ltd.

Kenneth Williams is a shareholder in the Segal McCambridge Detroit office. He focuses his practice on representing corporations and insurance carriers in the areas of coverage and personal injury litigation. He has a wide array of jury trial experience in Michigan, Florida, and Illinois. He has also litigated matters including but not limited to general liability, premises liability, coverage and indemnification, employment discrimination, along with agency claims. He is also co-chair of the firm’s Diversity & Inclusion Committee.


Card image cap

Similar Courses

Card image cap
63 minutes
40 Years of Data: What the Data on the Industry Says About Its Future
For 40 years, The American Lawyer, its affiliate publications and ALM Intelligence’s Legal Compass have been collecting data on law firms, clients and providers. What does the data tell us about where the industry is headed? We will take a deep dive into our data and others’ to assess the state of the industry and its future.

Legalweek

$65

Add to Cart
Card image cap
56 minutes
A Comprehensive Guide on SPAC Litigation and Enforcement: Hot Buttons Explored
Join securities law expert Adrienna Huffman (The Brattle Group) as she brings the audience a comprehensive discussion of recent SPAC-related acquisitions.We will delve into an in-depth analysis of the current trends, litigatio nrisks, and provide practical compliance strategies for transitioning private companies amidst a rapidly evolving legal climate.

The Knowledge Group

$75

Add to Cart
Card image cap
60 minutes
Alternative Energy & Renewables
This session’s panelists, all of whom have experience in the renewable energy and power sectors, will discuss valuation and other relevant issues in the context of expanding alternative and renewable energy sources, and the pressures this expansion will have on the merchant power sector.

American Bankruptcy Institute

$75

Add to Cart
Card image cap
74 minutes
Anatomy of a Pharmaceutical Bankruptcy Case
This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

American Bankruptcy Institute

$95

Add to Cart
Previous Next